Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- N/A
CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
SARS-CoV-2 Donor-Recipient Immunity Transfer
- Status
- COMPLETED
- Phase
- N/A
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
- Status
- COMPLETED
- Phase
- NA
Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.
- Status
- TERMINATED
- Phase
- NA
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
The Clinical Trial of Chidamide+Decitabine+Camrelizumab Versus Decitabine+Camrelizumab in Anti-PD-1 Antibody Resistant Patients With Classical Hodgkin Lymphoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Camrelizumab Plus Decitabine in Anti-PD-1 Treatment-naive Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Haplo Peripheral Blood Sct In GVHD Prevention
- Status
- COMPLETED
- Phase
- PHASE1
Immune Checkpoint Inhibitors and Radiotherapy in Relapsed/Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study
- Status
- COMPLETED
- Phase
- N/A
Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission
- Status
- COMPLETED
- Phase
- N/A
Camrelizumab(SHR-1210) Combined With GEMOX in Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE2